References
- Alaqad K, Saleh TA. Gold and silver nanoparticles: synthesis methods, characterization routes and applications towards drugs. J Environ Anal Toxicol. 2016; 6:384.
- Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 2011; 9:1035–52.
- Cheow WS, Hadinoto K. Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate. Colloids Surf B Biointerfaces. 2012; 92:55–63.
- Gao W, Thamphiwatana S, Angsantikul P, Zhang L. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014; 6:532–47.
- Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2012; 41:2256–82.
- Tiwari PM, Vig K, Dennis VA, Singh SR. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials (Basel). 2011; 1:31–63.
- Haider A, Haider S, Kang IK, Kumar A, Kummara MR, Kamal T, Han SS. A novel use of cellulose based filter paper containing silver nanoparticles for its potential application as wound dressing agent. Int J Biol Macromol. 2018; 108:455–61.
- Khampieng T, Wongkittithavorn S, Chaiarwut S, Ekabutr P, Pavasant P, Supaphol P. Silver nanoparticles-based hydrogel: characterization of material parameters for pressure ulcer dressing applications. J Drug Deliv Sci Technol. 2018; 44:91–100.
- Zhang Y, Shareena Dasari TP, Deng H, Yu H. Antimicrobial activity of gold nanoparticles and ionic gold. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015; 33:286–327.
- Maliszewska I, Kałas W, Wysokińska E, Tylus W, Pietrzyk N, Popko K, Palewska K. Enhancement of photo-bactericidal effect of tetrasulfonated hydroxyaluminum phthalocyanine on Pseudomonas aeruginosa. Lasers Med Sci. 2018; 33:79–88.
- Batista CCS, Albuquerque LJC, de Araujo I, Albuquerque BL, da Silva FD, Giacomelli FC. Antimicrobial activity of nano-sized silver colloids stabilized by nitrogen-containing polymers: the key influence of the polymer capping. RSC Adv. 2018; 8:10873–82.
- Panáček A, Kvítek L, Smékalová M, Večeřová R, Kolář M, Röderová M, et al. Bacterial resistance to silver nanoparticles and how to overcome it. Nat Nanotechnol. 2018; 13:65–71.
- Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004; 15:897–900.
- Young JJ, Cheng KM, Young YA, Chen XA, Chen YH, Chang TY. Chondroitin sulfate-stabilized silver nanoparticles: improved synthesis and their catalytic, antimicrobial, and biocompatible activities. Carbohydr Res. 2018; 457:14–24.
- Amin RM, Mohamed MB, Ramadan MA, Verwanger T, Krammer B. Rapid and sensitive microplate assay for screening the effect of silver and gold nanoparticles on bacteria. Nanomedicine (Lond). 2009; 4:637–43.
- Lima E, Guerra R, Lara V, Guzmán A. Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem Cent J. 2013; 7:11.
- Shamaila S, Zafar N, Riaz S, Sharif R, Nazir J, Naseem S. Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen. Nanomaterials (Basel). 2016; 6:71.
- Daima HK, Selvakannan PR, Shukla R, Bhargava SK, Bansal V. Fine-tuning the antimicrobial profile of biocompatible gold nanoparticles by sequential surface functionalization using polyoxometalates and lysine. PLoS One. 2013; 8:e79676.
- Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang X. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J Am Chem Soc. 2010; 132:12349–56.
- Bresee J, Bond CM, Worthington RJ, Smith CA, Gifford JC, Simpson CA. Nanoscale structure-activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics. J Am Chem Soc. 2014; 136:5295–300.
- Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D. Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother. 2013; 57:4945–55.
- Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 2014; 8:10682–6.
- Zhou Y, Kong Y, Kundu S, Cirillo JD, Liang H. Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin. J Nanobiotechnology. 2012; 10:19.
- Rai A, Prabhune A, Perry CC. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem. 2010; 20:6789–98.
- Junejo Y, Sirajuddin, Baykal A, Safdar M, Balouch A. A novel green synthesis and characterization of Ag NPs with its ultra-rapid catalytic reduction of methyl green dye. Appl Surf Sci. 2014; 290:499–503.
- Roshmi T, Soumya KR, Jyothis M, Radhakrishnan EK. Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin. Gold Bull. 2015; 48:63–71.
- Wang C, Kim YJ, Singh P, Mathiyalagan R, Jin Y, Yang DC. Green synthesis of silver nanoparticles by Bacillus methylotrophicus, and their antimicrobial activity. Artif Cells Nanomed Biotechnol. 2016; 44:1127–32.
- Shweta R, Parul S, Pritam V, Vishnu A. Nanoparticle-based drug delivery systems: promising approaches against infections. Braz Arch Biol Technol. 2014; 57:209–22.
- Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm. 2006; 314:72–82.
- Pinto-Alphandary H, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000; 13:155–68.
- Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013; 65:1803–15.
- Grace AN, Pandian K. Quinolone antibiotic-capped gold nanoparticles and their antibacterial efficacy against Gram positive and Gram negative organisms. J Bionanosci. 2007; 1:96–105.
- Burygin GL, Khlebtsov BN, Shantrokha AN, Dykman LA, Bogatyrev VA, Khlebtsov NG. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res Lett. 2009; 4:794–801.
- Markowska K, Grudniak AM, Krawczyk K, Wróbel I, Wolska KI. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles. J Med Microbiol. 2014; 63:849–54.
- Nisar M, Khan SA, Qayum M, Khan A, Farooq U, Jaafar HZ. Robust synthesis of Ciprofloxacin-capped metallic nanoparticles and their urease inhibitory assay. Molecules. 2016; 21:411.
- Nisar MF, Khan SA, Shah MR, Khan A, Farooq U, Uddin G, Ahmad B. Moxifloxacin-capped noble metal nanoparticles as potential urease inhibitors. New J Chem. 2015; 39:8080–6.
- Onyeji CO, Nightingale CH, Nicolau DP, Quintiliani R. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. Antimicrob Agents Chemother. 1994; 38:523–7.
- Armstead AL, Li B. Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine. 2011; 6:3281–93.
- Chen CW, Hsu CY, Lai SM, Syu WJ, Wang TY, Lai PS. Metal nanobullets for multidrug resistant bacteria and biofilms. Adv Drug Deliv Rev. 2014; 78:88–104.
- Tom RT, Suryanarayanan V, Reddy PG, Baskaran S, Pradeep T. Ciprofloxacin-protected gold nanoparticles. Langmuir. 2004; 20:1909–14.
- Shaikh AJ, Batool M, Yameen MA, Waseem A. Plasmonic effects, size and biological activity relationship of Au-Ag alloy nanoparticles. J Nano Res-SW. 2018; 54:98–111.
- McFarland FJ. The nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. JAMA. 1907; XLIX:1176–8.
- Susceptibility testing method—latest version. British Society for Antimicrobial Chemotherapy (BSAC) [online]. 2016 [cited]. Available from:
http://bsac.org.uk/stewardshipsurveillance/susceptibility/methodologylatestversion/ . - CLSI. Performance standards for antimicrobial susceptibility testing. Approved standard. 28th ed. CLSI supplement M100. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2016.